Precigen Statistics
Total Valuation
Precigen has a market cap or net worth of $569.13 million. The enterprise value is $514.53 million.
Important Dates
The last earnings date was Tuesday, August 12, 2025, after market close.
Earnings Date | Aug 12, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
Precigen has 297.97 million shares outstanding. The number of shares has increased by 16.06% in one year.
Current Share Class | 297.97M |
Shares Outstanding | 297.97M |
Shares Change (YoY) | +16.06% |
Shares Change (QoQ) | +0.87% |
Owned by Insiders (%) | 9.42% |
Owned by Institutions (%) | 27.43% |
Float | 147.67M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 127.59 |
Forward PS | n/a |
PB Ratio | n/a |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 118.55 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.71
Current Ratio | 2.71 |
Quick Ratio | 2.60 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -31,484.00 |
Financial Efficiency
Return on equity (ROE) is -668.03% and return on invested capital (ROIC) is -242.10%.
Return on Equity (ROE) | -668.03% |
Return on Assets (ROA) | -67.44% |
Return on Invested Capital (ROIC) | -242.10% |
Return on Capital Employed (ROCE) | -120.01% |
Revenue Per Employee | $30,350 |
Profits Per Employee | -$870,629 |
Employee Count | 143 |
Asset Turnover | 0.05 |
Inventory Turnover | n/a |
Taxes
Income Tax | -72,000 |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +78.51% in the last 52 weeks. The beta is 1.87, so Precigen's price volatility has been higher than the market average.
Beta (5Y) | 1.87 |
52-Week Price Change | +78.51% |
50-Day Moving Average | 1.63 |
200-Day Moving Average | 1.38 |
Relative Strength Index (RSI) | 59.06 |
Average Volume (20 Days) | 3,153,987 |
Short Selling Information
The latest short interest is 28.83 million, so 9.68% of the outstanding shares have been sold short.
Short Interest | 28.83M |
Short Previous Month | 28.43M |
Short % of Shares Out | 9.68% |
Short % of Float | 19.52% |
Short Ratio (days to cover) | 9.77 |
Income Statement
In the last 12 months, Precigen had revenue of $4.34 million and -$124.50 million in losses. Loss per share was -$0.43.
Revenue | 4.34M |
Gross Profit | -52.67M |
Operating Income | -94.45M |
Pretax Income | -97.34M |
Net Income | -124.50M |
EBITDA | -91.86M |
EBIT | -94.45M |
Loss Per Share | -$0.43 |
Full Income Statement Balance Sheet
The company has $59.75 million in cash and $5.15 million in debt, giving a net cash position of $54.60 million or $0.18 per share.
Cash & Cash Equivalents | 59.75M |
Total Debt | 5.15M |
Net Cash | 54.60M |
Net Cash Per Share | $0.18 |
Equity (Book Value) | -5.90M |
Book Value Per Share | -0.12 |
Working Capital | 39.56M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$66.28 million and capital expenditures -$3.50 million, giving a free cash flow of -$69.78 million.
Operating Cash Flow | -66.28M |
Capital Expenditures | -3.50M |
Free Cash Flow | -69.78M |
FCF Per Share | -$0.23 |
Full Cash Flow Statement Margins
Gross Margin | n/a |
Operating Margin | -2,176.31% |
Pretax Margin | -2,870.32% |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
Precigen does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -16.06% |
Shareholder Yield | -16.06% |
Earnings Yield | -21.88% |
FCF Yield | -12.26% |
Analyst Forecast
The average price target for Precigen is $6.00, which is 214.14% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $6.00 |
Price Target Difference | 214.14% |
Analyst Consensus | Strong Buy |
Analyst Count | 3 |
Revenue Growth Forecast (5Y) | 162.64% |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Precigen has an Altman Z-Score of -30.35 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -30.35 |
Piotroski F-Score | 3 |